CORT - Corcept Therapeutics Incorporated

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Breakdown
ttm
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Total Revenue
306,486
306,486
251,247
159,201
81,321
Cost of Revenue
5,504
5,504
5,215
3,554
2,058
Gross Profit
300,982
300,982
246,032
155,647
79,263
Operating Expenses
Research Development
89,017
89,017
75,247
40,376
23,844
Selling General and Administrative
100,359
100,359
81,289
62,416
45,240
Total Operating Expenses
189,376
189,376
156,536
102,792
69,084
Operating Income or Loss
111,606
111,606
89,496
52,855
10,179
Interest Expense
-
-
-
49
2,039
Income Before Tax
116,676
116,676
92,153
52,806
8,140
Income Tax Expense
22,495
22,495
16,743
-76,316
-
Income from Continuing Operations
94,181
94,181
75,410
129,122
8,140
Net Income
94,181
94,181
75,410
129,122
8,140
Net Income available to common shareholders
94,181
94,181
75,410
129,122
8,140
Basic EPS
-
-
0.65
1.14
0.07
Diluted EPS
-
-
0.60
1.04
0.07
Basic Average Shares
-
-
115,343
113,527
110,566
Diluted Average Shares
-
-
126,688
124,515
116,139
EBITDA
-
113,777
89,732
52,961
10,266